| Linden Oaks Hospital | |
| 852 S West Street, Naperville, Illinois 60540 | |
| (630) 305-5500 | |
| Not Available |
| Name | Linden Oaks Hospital |
|---|---|
| Type | Psychiatric Hospital |
| Location | 852 S West Street, Naperville, Illinois |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | No |
| Medicare ID (CCN) | 144035 |
| NPI Number | 1619910460 |
| Organization Name | NAPERVILLE PSYCHIATRIC VENTURES |
| Doing Business As | LINDEN OAKS HOSPITAL |
| Address | 801 S Washington St, Naperville, IL 60540 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 630-305-5500 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
Among more than 1,200 patients who underwent major abdominal surgery, a lower health literacy level was associated with a longer hospital length of stay, according to a study published by JAMA Surgery.
Treating paranasal sinus cancer with three-dimensional radiation that conforms to the shape of the tumor-a technique that minimizes side effects such as severe dry mouth and vision problems-is safe and effective, research at Fox Chase Cancer Center shows. Aruna Turaka, M.D., radiation oncologist at Fox Chase, will present the results on November 2nd at the annual meeting of the American Society for Radiation Oncology.
Researchers at Radboud university medical center have developed a 'deep learning' system that is better than most pathologists at determining the aggressiveness of prostate cancer. The AI system, which uses tissue samples to arrive at its diagnosis, taught itself to identify prostate cancer based on data from over 1200 patients.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
› Verified 1 days ago
| NPI Number | 1871628362 |
| Organization Name | NAPERVILLE PSYCHIATRIC VENTURES |
| Doing Business As | LINDEN OAKS HOSPITAL |
| Address | 801 S Washington St, Naperville, IL 60540 |
| Hospital Type | Psychiatric Hospital |
| Phone Number | 630-305-5500 |
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
Among more than 1,200 patients who underwent major abdominal surgery, a lower health literacy level was associated with a longer hospital length of stay, according to a study published by JAMA Surgery.
Treating paranasal sinus cancer with three-dimensional radiation that conforms to the shape of the tumor-a technique that minimizes side effects such as severe dry mouth and vision problems-is safe and effective, research at Fox Chase Cancer Center shows. Aruna Turaka, M.D., radiation oncologist at Fox Chase, will present the results on November 2nd at the annual meeting of the American Society for Radiation Oncology.
Researchers at Radboud university medical center have developed a 'deep learning' system that is better than most pathologists at determining the aggressiveness of prostate cancer. The AI system, which uses tissue samples to arrive at its diagnosis, taught itself to identify prostate cancer based on data from over 1200 patients.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
› Verified 1 days ago
News Archive
Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for VELCADE(bortezomib), which updates the label to include the subcutaneous method of administration in all approved indications: multiple myeloma and mantle cell lymphoma after at least one prior therapy.
Among more than 1,200 patients who underwent major abdominal surgery, a lower health literacy level was associated with a longer hospital length of stay, according to a study published by JAMA Surgery.
Treating paranasal sinus cancer with three-dimensional radiation that conforms to the shape of the tumor-a technique that minimizes side effects such as severe dry mouth and vision problems-is safe and effective, research at Fox Chase Cancer Center shows. Aruna Turaka, M.D., radiation oncologist at Fox Chase, will present the results on November 2nd at the annual meeting of the American Society for Radiation Oncology.
Researchers at Radboud university medical center have developed a 'deep learning' system that is better than most pathologists at determining the aggressiveness of prostate cancer. The AI system, which uses tissue samples to arrive at its diagnosis, taught itself to identify prostate cancer based on data from over 1200 patients.
Halo Healthcare, Inc. announces it has acquired the assets of NeoMatrix, LLC and has restructured the Company, including engaging a new CEO and management team, appointing a new Board of Directors, and relaunching the HALO diagnostic device for breast cancer risk assessment.
› Verified 1 days ago
Edward Hospital Acute Care Hospital Location: 801 South Washington, Naperville, Illinois 60540 Phone: (630) 527-3000 | |
Linden Oaks Hospital Psychiatric Hospital Location: 852 S West Street, Naperville, Illinois 60540 Phone: (630) 305-5500 |